StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Acquisition & Divestiture-Related Pre-Tax Charges by Quarter

Acquisition & Divestiture-Related Pre-Tax Charges ($M) ($M)

QuarterlyAnnual

Merck Acquisition & Divestiture-Related Pre-Tax Charges: $191M in Q2 2026, up 213.1% from a year earlier.

Latest, Q2 2026
191
Period ended Jun 30, 2026
Change on a year earlier
+213.1%
61 in Q2 2025
History
24 quarters
Since Q4 2016
Sources
22
Documents cited below

Where the Q2 2026 figure comes from

“|| Loss Before Taxes | (683 | ) | (1,090 | ) | (334 | ) | 191 | (1,233 | ) | 550”

Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗

Reported in Form 8-K Table 2a.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAcquisition & Divestiture-Related Pre-Tax Charges ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026191+213.1%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2026Mar 31, 20261,046–Form 8-K (tm2612241d1_ex99-1.htm, filed 2026-04-30) ↗
Q4 2025Dec 31, 20251,107–Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q2 2025Jun 30, 202561–Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q4 2023Dec 31, 20231,233+3.4%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
Q4 2022Dec 31, 20221,192–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
Q3 2022Sep 30, 20221,344+96.5%Form 8-K (tm2328962d1_ex99-1.htm, filed 2023-10-26) ↗
Q3 2021Sep 30, 2021684+97.7%Form 8-K (tm2227726d1_ex99-1.htm, filed 2022-10-27) ↗
Q2 2021Jun 30, 2021258-49.5%Form 8-K (tm2123400d1_ex99-1.htm, filed 2021-07-29) ↗
Q4 2020Dec 31, 20202,042-44.9%Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗
Q3 2020Sep 30, 2020346-77.7%Form 8-K (tm2131077d1_ex99-1.htm, filed 2021-10-28) ↗
Q2 2020Jun 30, 2020511-51.0%Form 8-K (tm2123400d1_ex99-1.htm, filed 2021-07-29) ↗
Q4 2019Dec 31, 20193,704+38.2%Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗
Q3 2019Sep 30, 20191,551-29.0%Form 8-K (tm2032785d1_ex99-1.htm, filed 2020-10-27) ↗
Q2 2019Jun 30, 20191,043-13.7%Form 8-K (tm2026006d1_ex99-1.htm, filed 2020-07-31) ↗
Q4 2018Dec 31, 20182,681-12.6%Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗

Cite this data

StockData. (2026). Merck Acquisition & Divestiture-Related Pre-Tax Charges ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap-adj-acq-pretax

See every metric in the Merck KPI table. Data updated Oct 26, 2026.